| scholarly article | Q13442814 |
| P819 | ADS bibcode | 2017PLoSO..1279081H |
| P356 | DOI | 10.1371/JOURNAL.PONE.0179081 |
| P932 | PMC publication ID | 5489160 |
| P698 | PubMed publication ID | 28658301 |
| P50 | author | Yao-Min Hung | Q88407735 |
| P2093 | author name string | Chyong-Mei Chen | |
| Yu-Hsun Wang | |||
| James Cheng-Chung Wei | |||
| Jeng-Yuan Chiou | |||
| Lichi Lin | |||
| Paul Yung-Pou Wang | |||
| P2860 | cites work | Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: meta-analyses of individual participant data from randomised trials | Q24619410 |
| Nationwide population-based epidemiologic study of rheumatoid arthritis in Taiwan | Q47887979 | ||
| Cardiovascular disease and risk factors in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis. | Q53249650 | ||
| Imprecision: Limitations to Interpretation of a Large Randomized Clinical Trial. | Q54962455 | ||
| Endothelium-dependent dilation in the systemic arteries of asymptomatic subjects relates to coronary risk factors and their interaction | Q72726614 | ||
| Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease | Q73708513 | ||
| Antirheumatic drug use and the risk of acute myocardial infarction | Q80016233 | ||
| Treatment with tumor necrosis factor blockers is associated with a lower incidence of first cardiovascular events in patients with rheumatoid arthritis | Q81922641 | ||
| Sulfasalazine might reduce risk of cardiovascular diseases in patients with ankylosing spondylitis: A nationwide population-based retrospective cohort study | Q88950996 | ||
| Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group | Q28138338 | ||
| Selective COX-2 inhibition improves endothelial function in coronary artery disease | Q28194726 | ||
| Patients exposed to rofecoxib and celecoxib have different odds of nonfatal myocardial infarction | Q28214120 | ||
| Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial | Q28217835 | ||
| Cardiovascular risk associated with celecoxib in a clinical trial for colorectal adenoma prevention | Q29620087 | ||
| EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis | Q33505914 | ||
| Subgroup analyses to determine cardiovascular risk associated with nonsteroidal antiinflammatory drugs and coxibs in specific patient groups. | Q33908100 | ||
| Cardiovascular complications of rheumatoid arthritis: assessment, prevention, and treatment | Q33943374 | ||
| Subclinical atherosclerosis and endothelial dysfunction in patients with early rheumatoid arthritis as evidenced by measurement of carotid intima-media thickness and flow-mediated vasodilatation: an observational study. | Q34061038 | ||
| A cohort study to evaluate cardiovascular risk of selective and nonselective cyclooxygenase inhibitors (COX-Is) in arthritic patients attending orthopedic department of a tertiary care hospital | Q34259503 | ||
| Coxibs and cardiovascular disease | Q34356732 | ||
| Cardiovascular Safety of Celecoxib, Naproxen, or Ibuprofen for Arthritis | Q34547253 | ||
| Systemic inflammation and cardiovascular risk factors predict rapid progression of atherosclerosis in rheumatoid arthritis | Q34550743 | ||
| Risk of cardiovascular mortality in patients with rheumatoid arthritis: a meta-analysis of observational studies | Q34889152 | ||
| Risk of major cardiovascular events in patients with psoriatic arthritis, psoriasis and rheumatoid arthritis: a population-based cohort study. | Q35124825 | ||
| Taiwan's new national health insurance program: genesis and experience so far. | Q35131593 | ||
| Disease-modifying antirheumatic drugs are associated with a reduced risk for cardiovascular disease in patients with rheumatoid arthritis: a case control study | Q35605663 | ||
| Utility of the Framingham risk score to predict the presence of coronary atherosclerosis in patients with rheumatoid arthritis | Q35630128 | ||
| Reduction in the incidence of myocardial infarction in patients with rheumatoid arthritis who respond to anti-tumor necrosis factor alpha therapy: results from the British Society for Rheumatology Biologics Register | Q36732112 | ||
| Cardiovascular disease in patients with rheumatoid arthritis: results from the QUEST-RA study | Q36757060 | ||
| Hydroxychloroquine Use Is Associated With Decreased Incident Cardiovascular Events in Rheumatoid Arthritis Patients | Q36877859 | ||
| Cardiovascular manifestations of rheumatologic diseases | Q36999472 | ||
| Celecoxib and sulfasalazine had negative association with coronary artery diseases in patients with ankylosing spondylitis: A nation-wide, population-based case-control study | Q37257008 | ||
| Trends in cardiovascular mortality in patients with rheumatoid arthritis over 50 years: a systematic review and meta-analysis of cohort studies. | Q37583248 | ||
| High risk of clinical cardiovascular events in rheumatoid arthritis: Levels of associations of myocardial infarction and stroke through a systematic review and meta-analysis | Q37775403 | ||
| Validation of the National Health Insurance Research Database with ischemic stroke cases in Taiwan | Q37847116 | ||
| Cardiovascular disease in autoimmune rheumatic diseases. | Q38094402 | ||
| Rheumatoid arthritis and cardiovascular disease | Q38149252 | ||
| Coexistence of ischemic heart disease and rheumatoid arthritis patients-A case control study | Q38710725 | ||
| How accurate are diagnoses for rheumatoid arthritis and juvenile idiopathic arthritis in the general practice research database? | Q39521686 | ||
| Systemic nature of endothelial dysfunction in atherosclerosis | Q40598028 | ||
| Prognostic value of coronary vascular endothelial dysfunction | Q44090667 | ||
| COX-2 selective non-steroidal anti-inflammatory drugs and risk of serious coronary heart disease | Q44182620 | ||
| Differential effects of selective cyclooxygenase-2 inhibitors on endothelial function in salt-induced hypertension | Q44642006 | ||
| Anti-rheumatic drug use and risk of hospitalization for congestive heart failure in rheumatoid arthritis | Q45129989 | ||
| Risk of hospitalization for myocardial infarction among users of rofecoxib, celecoxib, and other NSAIDs: a population-based case-control study | Q46481473 | ||
| Association between a history of periodontitis and the risk of rheumatoid arthritis: a nationwide, population-based, case-control study | Q47196075 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | rheumatoid arthritis | Q187255 |
| P304 | page(s) | e0179081 | |
| P577 | publication date | 2017-06-28 | |
| P1433 | published in | PLOS One | Q564954 |
| P1476 | title | The effect of anti-rheumatic medications for coronary artery diseases risk in patients with rheumatoid arthritis might be changed over time: A nationwide population-based cohort study | |
| P478 | volume | 12 |
| Q60935904 | Acupuncture decreased the risk of coronary heart disease in patients with rheumatoid arthritis in Taiwan: a Nationwide propensity score-matched study |
| Q55208303 | Chloroquine and hydroxychloroquine are associated with reduced cardiovascular risk: a systematic review and meta-analysis. |
| Q92122504 | Immunotherapy for the rheumatoid arthritis-associated coronary artery disease: promise and future |
| Q90533374 | Transplantation of human ESC-derived mesenchymal stem cell spheroids ameliorates spontaneous osteoarthritis in rhesus macaques |
Search more.